IP Library Granted Patent US 10,576,204
Granted Patent B2
US 10,576,204 · App. 15/714,084 · Granted Mar 3, 2020

Infusion pump systems and methods

Inventors: Mark C. Estes (Malibu, CA); Wenkang Qi (Cupertino, CA); Phillip Hopper (San Carlos, CA)
Assignee: Bigfoot Biomedical, Inc.
A61M5/172A61M5/14244A61M5/168A61M5/1723F04B17/03F04B19/22G06F19/3468A61M5/1413A61M2205/35A61M2205/3569A61M2205/3592A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,576,204
App. No.
15/714,084
Granted
Mar 3, 2020
Kind
B2
Abstract

Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.

Claims (14)

1. An insulin delivery system, comprising:

at least a first disposable insulin delivery device and at least a second disposable insulin delivery device, wherein each of the first and second disposable insulin delivery devices each comprise:

a fluid cartridge comprising a plunger at a first end of the fluid cartridge, a septum at the second end of the fluid cartridge, and insulin medication,

a housing that defines a space to receive the fluid cartridge, and

a drive system configured to dispense the insulin medicine from the insulin delivery device,

wherein the first disposable insulin delivery device is of a different type than the second disposable insulin delivery device, wherein the insulin medication in the first disposable insulin delivery device is different from the insulin medication in the second disposable insulin delivery device;

a body-worn glucose monitoring device; and

a controller device removably attachable to each of the first and second insulin delivery devices, the controller device being adapted to determine the type of a disposable insulin delivery device secured to the controller device, the controller device comprising a user interface display, wherein the controller device is configured to automatically enable wireless communication with the body-worn glucose monitoring device in response to the controller device being connected to the first disposable insulin delivery device and to disable wireless communication with the body-worn glucose monitoring device in response to the controller being connected to the second disposable insulin delivery device, wherein the controller device is configured to display a user's glucose level when data from the body-worn glucose monitoring device is wirelessly received by the controller device when wireless communication with the body-worn glucose monitoring device is enabled, wherein the controller device is enabled to provide customized insulin delivery options for each of the first and second disposable insulin delivery devices tailored to the pharmakinetic characteristics of the insulin medication in each disposable insulin delivery device, wherein the controller device is configured to notify the user of the type of medication in the disposable insulin delivery device reversibly attached to the controller device when the controller device is reversibly attached to the disposable insulin delivery device.

2. The system of claim 1 , wherein the first disposable insulin delivery device and the second disposable insulin delivery device are insulin pump devices.

3. The system of claim 2 , wherein the controller device forms an electrical connection with one of the insulin pump devices reversibly connected to the controller device.

4. The system of claim 3 , wherein the controller device reads a therapy parameter from the insulin pump device connected to the controller device.

5. The system of claim 1 , wherein the insulin pump devices each comprise a battery.

6. The system of claim 1 , wherein the controller device forms an electrical connection to each disposable insulin delivery device when reversibly attached thereto.

7. The system of claim 6 , wherein each disposable insulin delivery device comprises a means for indicating the type of disposable insulin delivery device, the indicating means being recognizable by the controller device in response to the electrical connection.

Assignments (18)
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 063239/0684 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: ASANTE LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 050927/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: ASANTE SOLUTIONS, INC.
To: ASANTE LLC
Reel/Frame 050927/0393 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: ESTES, MARK C.; QI, WENKANG; HOPPER, PHILLIP
To: ASANTE SOLUTIONS, INC.
Reel/Frame 050912/0811 →